It has been shown that FN expression is elevated in many solid tumors and is presumably involved in tumor progression, angiogenesis, metastasis, and chemoresistance since cancerous cells and endothelial cells can produce more FN molecules than those that are secreted from fibroblasts within the originated non-cancerous cells [42,45,46,47]. This evidence concerns the gene FN1 and neoplasm.